The April content release includes the following updates:

FDA Approval Packages:

• 1 new drug: Aliskiren Hemifumarate; Amlodipine Besylate; Hydrochlorothiazide
• 808 new FDA approval documents
• 16,887 new pages of FDA approval documents

Extracted Safety data observations

• 17,990 new extracted safety data lines

Extracted PK data observations

• 22,921 new extracted PK data lines

AERS (post-marketing) reports

• 200,059 new reports
• Latest AERS version Q3 2010 was installed

FDA Advisory Committee Documents

• 299 new documents
• 17,557 new pages

• 1,449,295 pages of FDA approval documents (Including FDA Classic Collection)
• 61,170 FDA approval documents (Including FDA Classic Collection)
• 4,065 drugs with data in PharmaPendium
• 1,000,832 extracted data lines in the drug safety database
• 1,104,132 extracted PK data lines
• 3,762,144 AERS (post-marketing) reports
• 4,209 documents / 76,522 pages of EMA approval documents
• 10,906 documents / 308,015 pages of FDA Classic Collection
• 9,851 documents / 402,033 pages of FDA Advisory Committee Meeting documents